Which gastrointestinal side effects were very common in newly transplanted patients receiving belatacept in clinical trials?

Diarrhoea, constipation, nausea, vomiting and abdominal pain were very common (≥1/10) gastrointestinal adverse reactions in newly transplanted patients receiving belatacept, reported cumulatively up to Year 3 and pooled across the more intensive and less intensive regimens.